Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

Docosahexaenoic acid inhibits hepatic stellate cell activation to attenuate liver fibrosis in a PPARγ-dependent manner.

He J, Hong B, Bian M, Jin H, Chen J, Shao J, Zhang F, Zheng S.

Int Immunopharmacol. 2019 Oct;75:105816. doi: 10.1016/j.intimp.2019.105816. Epub 2019 Aug 19.

PMID:
31437794
2.

Dihydroartemisinin attenuates alcoholic fatty liver through regulation of lipin-1 signaling.

Chen X, Bian M, Jin H, Lian N, Shao J, Zhang F, Zheng S.

IUBMB Life. 2019 Jul 2. doi: 10.1002/iub.2113. [Epub ahead of print]

PMID:
31265202
3.

Periostin in chronic liver diseases: Current research and future perspectives.

Jia Y, Zhong F, Jiang S, Guo Q, Jin H, Wang F, Li M, Wang L, Chen A, Zhang F, Shao J, Zheng S.

Life Sci. 2019 Jun 1;226:91-97. doi: 10.1016/j.lfs.2019.04.021. Epub 2019 Apr 9. Review.

PMID:
30978348
4.

Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells.

Wang F, Jia Y, Li M, Wang L, Shao J, Guo Q, Tan S, Ding H, Chen A, Zhang F, Zheng S.

Cell Commun Signal. 2019 Feb 11;17(1):11. doi: 10.1186/s12964-019-0324-8.

5.

P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.

Wang L, Zhang Z, Li M, Wang F, Jia Y, Zhang F, Shao J, Chen A, Zheng S.

IUBMB Life. 2019 Jan;71(1):45-56. doi: 10.1002/iub.1895. Epub 2018 Oct 15.

PMID:
30321484
6.

Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells.

Jia Y, Wang F, Guo Q, Li M, Wang L, Zhang Z, Jiang S, Jin H, Chen A, Tan S, Zhang F, Shao J, Zheng S.

Redox Biol. 2018 Oct;19:375-387. doi: 10.1016/j.redox.2018.09.007. Epub 2018 Sep 7.

7.

Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.

Zhang Z, Yao Z, Wang L, Ding H, Shao J, Chen A, Zhang F, Zheng S.

Autophagy. 2018;14(12):2083-2103. doi: 10.1080/15548627.2018.1503146. Epub 2018 Aug 21.

PMID:
30081711
8.

Oroxylin A prevents alcohol-induced hepatic steatosis through inhibition of hypoxia inducible factor 1alpha.

Jin H, Lian N, Bian M, Zhang C, Chen X, Shao J, Wu L, Chen A, Guo Q, Zhang F, Zheng S.

Chem Biol Interact. 2018 Apr 1;285:14-20. doi: 10.1016/j.cbi.2018.02.025. Epub 2018 Feb 21.

PMID:
29476730
9.

Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.

Chen W, Zhang Z, Yao Z, Wang L, Zhang F, Shao J, Chen A, Zheng S.

Int Immunopharmacol. 2018 Mar;56:148-155. doi: 10.1016/j.intimp.2018.01.029. Epub 2018 Feb 3.

PMID:
29414645
10.

Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α.

Zhang F, Lu S, He J, Jin H, Wang F, Wu L, Shao J, Chen A, Zheng S.

Theranostics. 2018 Jan 1;8(3):610-626. doi: 10.7150/thno.22237. eCollection 2018.

11.

Oroxylin A inhibits ethanol-induced hepatocyte senescence via YAP pathway.

Jin H, Lian N, Bian M, Zhang C, Chen X, Shao J, Wu L, Chen A, Guo Q, Zhang F, Zheng S.

Cell Prolif. 2018 Jun;51(3):e12431. doi: 10.1111/cpr.12431. Epub 2018 Jan 10.

PMID:
29318697
12.

Perilipin 5 and liver fatty acid binding protein function to restore quiescence in mouse hepatic stellate cells.

Lin J, Zheng S, Attie AD, Keller MP, Bernlohr DA, Blaner WS, Newberry EP, Davidson NO, Chen A.

J Lipid Res. 2018 Mar;59(3):416-428. doi: 10.1194/jlr.M077487. Epub 2018 Jan 9.

13.

Effects of docosahexaenoic acid on locomotor activity in ethanol-treated HIV-1 transgenic rats.

He J, Huang W, Zheng S, Vigorito M, Chang SL.

J Neurovirol. 2018 Feb;24(1):88-97. doi: 10.1007/s13365-017-0597-x. Epub 2017 Dec 19.

14.

Dihydroartemisinin inhibits ER stress-mediated mitochondrial pathway to attenuate hepatocyte lipoapoptosis via blocking the activation of the PI3K/Akt pathway.

Chen X, Bian M, Zhang C, Kai J, Yao Z, Jin H, Lu C, Shao J, Chen A, Zhang F, Zheng S.

Biomed Pharmacother. 2018 Jan;97:975-984. doi: 10.1016/j.biopha.2017.11.010. Epub 2017 Nov 7.

PMID:
29136776
15.

Lipophagy and liver disease: New perspectives to better understanding and therapy.

Zhang Z, Yao Z, Chen Y, Qian L, Jiang S, Zhou J, Shao J, Chen A, Zhang F, Zheng S.

Biomed Pharmacother. 2018 Jan;97:339-348. doi: 10.1016/j.biopha.2017.07.168. Epub 2017 Nov 6. Review.

PMID:
29091883
16.

Magnesium isoglycyrrhizinate promotes the activated hepatic stellate cells apoptosis via endoplasmic reticulum stress and ameliorates fibrogenesis in vitro and in vivo.

Bian M, Chen X, Zhang C, Jin H, Wang F, Shao J, Chen A, Zhang F, Zheng S.

Biofactors. 2017 Nov;43(6):836-846. doi: 10.1002/biof.1390. Epub 2017 Oct 19.

PMID:
29048780
17.

Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats.

He J, Bai K, Hong B, Zhang F, Zheng S.

Int Immunopharmacol. 2017 Dec;53:56-62. doi: 10.1016/j.intimp.2017.09.013. Epub 2017 Oct 15.

PMID:
29035816
18.

Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP/HIF-1α signaling.

Zhang C, Bian M, Chen X, Jin H, Zhao S, Yang X, Shao J, Chen A, Guo Q, Zhang F, Zheng S.

J Cell Biochem. 2018 Feb;119(2):2258-2268. doi: 10.1002/jcb.26388. Epub 2017 Oct 18.

PMID:
28857294
19.

Nrf2 activation is required for curcumin to induce lipocyte phenotype in hepatic stellate cells.

Lu C, Xu W, Zheng S.

Biomed Pharmacother. 2017 Nov;95:1-10. doi: 10.1016/j.biopha.2017.08.037. Epub 2017 Aug 18.

PMID:
28826090
20.

Interaction between autophagy and senescence is required for dihydroartemisinin to alleviate liver fibrosis.

Zhang Z, Yao Z, Zhao S, Shao J, Chen A, Zhang F, Zheng S.

Cell Death Dis. 2017 Jun 15;8(6):e2886. doi: 10.1038/cddis.2017.255.

Supplemental Content

Loading ...
Support Center